Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication

被引:0
|
作者
Caifeng Shi
Yemeng Wan
Aiqin He
Xiaomei Wu
Xinjia Shen
Xueting Zhu
Junwei Yang
Yang Zhou
机构
[1] Second Affiliated Hospital of Nanjing Medical University,Center for Kidney Disease
来源
Acta Diabetologica | 2023年 / 60卷
关键词
Metabolite; Inflammation; Kidney;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1199 / 1207
页数:8
相关论文
共 50 条
  • [21] Upregulation of VSIG4 in Type 2 Diabetic Kidney Disease
    Han, Sang Youb
    Ghee, Jung Yeon
    Cha, Jin Joo
    Kang, Young Sun
    Hur, Dae Young
    Kim, Han Seong
    Cha, Dae Ryong
    LIFE-BASEL, 2022, 12 (07):
  • [22] Mitochondrial DNA Changes in Blood and Urine Display a Specific Signature in Relation to Inflammation in Normoalbuminuric Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients
    Petrica, Ligia
    Vlad, Adrian
    Gadalean, Florica
    Muntean, Danina Mirela
    Vlad, Daliborca
    Dumitrascu, Victor
    Bob, Flaviu
    Milas, Oana
    Suteanu-Simulescu, Anca
    Glavan, Mihaela
    Jianu, Dragos Catalin
    Ursoniu, Sorin
    Balint, Lavinia
    Mogos-Stefan, Maria
    Ienciu, Silvia
    Cretu, Octavian Marius
    Popescu, Roxana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (12)
  • [23] Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression
    Mosterd, C. M.
    Kanbay, M.
    van den Born, B. J. H.
    van Raalte, D. H.
    Rampanelli, E.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (03)
  • [24] Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease
    Fang, Ling-na
    Zhong, Shao
    Huang, Li-ji
    Lu, Bing
    Shen, Li-wen
    Tang, Feng-yan
    Sun, He-ping
    Zhang, Li
    CURRENT MEDICAL SCIENCE, 2020, 40 (06): : 1114 - 1120
  • [25] Micheliolide ameliorates diabetic kidney disease by inhibiting Mtdh-mediated renal inflammation in type 2 diabetic db/db mice
    Liu, Wenting
    Chen, Xiaowen
    Wang, Yuxian
    Chen, Yihua
    Chen, Sijia
    Gong, Wangqiu
    Chen, Ting
    Sun, Lingzhi
    Zheng, Chenghao
    Yin, Bohui
    Li, Shuting
    Luo, Congwei
    Huang, Qianyin
    Xiao, Jing
    Xu, Zhaozhong
    Peng, Fenfen
    Long, Haibo
    PHARMACOLOGICAL RESEARCH, 2019, 150
  • [26] Managing Chronic Kidney Disease in Type 2 Diabetes in Family Practice
    Scott, David
    Davidson, Jaime A.
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2011, 103 (9-10) : 952 - 959
  • [27] A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes
    Altman, Jeremy
    Bai, Shan
    Purohit, Sharad
    White, John
    Steed, Dennis
    Liu, Su
    Hopkins, Diane
    She, Jin-Xiong
    Sharma, Ashok
    Zhi, Wenbo
    JOURNAL OF PROTEOMICS, 2024, 300
  • [28] Protective Effect of Irbesartan by Inhibiting ANGPTL2 Expression in Diabetic Kidney Disease
    Ling-na Fang
    Shao Zhong
    Li-ji Huang
    Bing Lu
    Li-wen Shen
    Feng-yan Tang
    He-ping Sun
    Li Zhang
    Current Medical Science, 2020, 40 : 1114 - 1120
  • [29] Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the Four Horsemen of the Apocalypse
    Turkmen, Kultigin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (05) : 837 - 844
  • [30] Urinary proteins detected using modern proteomics intervene in early type 2 diabetic kidney disease - a pilot study
    Golea-Secara, Alina
    Munteanu, Cristian
    Sarbu, Mirela
    Cretu, Octavian M.
    Velciov, Silvia
    Vlad, Adrian
    Bob, Flaviu
    Gadalean, Florica
    Gluhovschi, Cristina
    Milas, Oana
    Simulescu, Anca
    Mogos-Stefan, Maria
    Patruica, Mihaela
    Petrica, Ligia
    Zamfir, Alina D.
    BIOMARKERS IN MEDICINE, 2020, 14 (16) : 1521 - 1537